Setting Forth the Regulatory Considerations for the Implementation of Liquid Biopsy in Oncology Clinical Trials

Time: 12:00 pm
day: Day Two Track B AM

Details:

  • Gaining an understanding of the various applications for LBx in oncology clinical trials and their individual regulatory requirements
  • Understanding the pros and cons of different clinical trial enrolment strategies and their downstream regulatory consequences
  • Exploring the multiple Liquid Biopsy Companion Diagnostic filing strategies to determine which one is best suited for your program

Speakers: